[Patient follow-up after treatment for breast cancer].
Patient follow-up after treatment for a breast cancer is based on the local recurrence risk. Annual mammography remains the main point of this follow-up and tumor markers detection has still no interest. Absence of benefit of an intensive clinical, biological and radiological surveillance has been proved for a long time but expert recommendations still are a subject of discussion although they knew no evolution for more than 10 years. Evolution of those follow-up modalities will depend on the future indications of MRI and PET. About distant recurrence, a better knowledge of the risk is now possible thanks to the tumor biological profile study. Nevertheless, intensification of follow-up for some kind of high-risk tumors will have interest only if we can propose a therapeutic alternative in metastatic situation.
Service de chirurgie oncologique, centre de lutte contre le cancer René-Gauducheau, institut de cancérologie de Nantes-Atlantique, boulevard Jacques-Monod, 44805 Nantes-Saint-Herblain, France. jm-classe@nantes.fnclcc.fr
J-M
JM
Classe
L
L
Sentilhes
I
I
Jaffré
M
M
Mezzadri
C
C
Lefebvre-Lacoeuille
M
M
Dejode
L
L
Catala
V
V
Bordes
F
F
Dravet
P
P
Descamps
D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000473:pathology / Q000523:psychology / Q000628:therapy*; D005260:Female; D006801:Humans; D008327:Mammography; D009362:Neoplasm Metastasis / Q000175:diagnosis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D014408:Biomarkers, Tumor